Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
oleh: Pedram Fadavi, Amir Mohammad Arefpour, Ramyar Hariri, Maryam Vasheghani, Maryam Garousi, Farzad Taghizadeh‐Hesary
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2021-10-01 |
Deskripsi
Abstract Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.